The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim test

Bernadeta Szewczyk1, Ewa Poleszak2, Piotr Wlaź3, Andrzej Wróbel4, Eliza Blicharska5, Agnieszka Cichy6, Małgorzata Dybała6, Agata Siwek6, Lucyna Pomierny-Chamioło6, Anna Piotrowska6, Piotr Brański7, Andrzej Pilc7,8, Gabriel Nowak1,6
1Laboratory of Trace Elements Neurobiology, Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, PL 31-343 Kraków, Poland
2Department of Pharmacology and Pharmacodynamics, Medical University of Lublin, Staszica 4, PL 20-081 Lublin, Poland
3Department of Animal Physiology, Institute of Biology, Maria Curie-Skłodowska University, Akademicka 19, PL 20-033 Lublin, Poland
4Second Department of Gynecology, Medical University of Lublin, Jaczewskiego 8, PL 20-090 Lublin, Poland
5Department of Analytical Chemistry, Medical University of Lublin, Staszica 6, PL 20-081 Lublin, Poland
6Laboratory of Pharmacobiology, Department of Cytobiology and Histochemistry, Collegium Medicum, Jagiellonian University, Medyczna 9, PL 30-688 Kraków, Poland
7Department of Neurobiology, Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, PL 31-343 Kraków, Poland
8Institute of Public Health, Collegium Medicum, Jagiellonian University, Grzegórzecka 20, PL 31-531 Krakow, Poland

Tài liệu tham khảo

Abert, 2004, 5-HT1A receptors, gene repression, and depression: guilt by association, Neuroscientist, 10, 575, 10.1177/1073858404267382 Celada, 2004, The therapeutic role of 5-HT1A and 5-HT2A receptors in depression, J Psychiatry Neurosci, 29, 252 Cieslik, 2007, Influence of zinc supplementation on imipramine effect in a chronic unpredictable stress (CUS) model in rats, Pharmacol Rep, 59, 46 Cryan, 2000, 5-HT1A and beyond: the role of serotonin and its receptors in depression and the antidepressant response, Hum Psychopharmacol, 15, 113, 10.1002/(SICI)1099-1077(200003)15:2<113::AID-HUP150>3.0.CO;2-W Cunha, 2008, Interaction of zinc with antidepressants in the tail suspension test, Prog Neuro-psychopharmacol Biol, 32, 1913, 10.1016/j.pnpbp.2008.09.006 Deakin, 1988, 5-HT2 receptors, depression and anxiety, Pharmacol Biochem Behav, 29, 819, 10.1016/0091-3057(88)90215-8 Detke, 1995, Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants, Psychopharmacology, 121, 66, 10.1007/BF02245592 Franco, 2007, Involvement of glutathione, ERK1/2 phosphorylation and BDNF expression in the antidepressant-like effect of zinc, Behav Brain Res, 188, 316, 10.1016/j.bbr.2007.11.012 Frederickson, 2005, The neurobiology of zinc in health and disease, Nat Rev, Neurosci, 6, 449, 10.1038/nrn1671 Garcia-Colunga, 2005, Zinc modulation of serotonin uptake in the adult rat corpus callosum, J Neurosci Res, 80, 145, 10.1002/jnr.20421 Głowinski, 1964, Inhibition of uptake of tritiated-noradrenaline in the intact rat brain by imipramine and structurally related compounds, Nature, 204, 1318, 10.1038/2041318a0 Haase, 2005, Fluctuations of cellular, available zinc modulate insulin signaling via inhibition of protein tyrosine phosphatases, J Trace Elem Med Biol, 19, 37, 10.1016/j.jtemb.2005.02.004 Harrison, 1994, Zn2+: an endogenous modulator of ligand- and voltage-gated ion channels, Neuropharmacology, 33, 935, 10.1016/0028-3908(94)90152-X Hyttel, 1977, Neurochemical characterization of a new potent and selective serotonin uptake inhibitor: Lu 10-171, Psychopharmacology, 51, 225, 10.1007/BF00431629 Hyttel, 1994, Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs), Int Clin Psychopharmacol, 9, 19, 10.1097/00004850-199403001-00004 Koe, 1966, p-Chlorophenylalanine: a specific depletor of brain serotonin, J Pharmacol Exp Ther, 154, 499 Krezel, 2007, The zinc/thiolate redox biochemistry of metallothionein and the control of zinc ion fluctuations in cell signaling, Arch Biochem Biophys, 463, 188, 10.1016/j.abb.2007.02.017 Kroczka, 2000, Zinc exhibits an antidepressant-like effect in the forced swimming test in mice, Pol J Pharmacol, 52, 403 Kroczka, 2001, Antidepressant-like properties of zinc in rodent forced swim test, Brain Res Bull, 55, 297, 10.1016/S0361-9230(01)00473-7 Li, 2001, Induction of mossy fiber Ä Ca3 long-term potentiation requires translocation of synaptically released Zn2+, J Neurosci, 21, 8015, 10.1523/JNEUROSCI.21-20-08015.2001 Lobato, 2008, Involvement of the adenosine A1 and A2A receptors in the antidepressant-like effect of zinc in the forced swimming test, Prog Neuro-psychopharmacol Biol Psychiatry, 32, 994, 10.1016/j.pnpbp.2008.01.012 Löscher, 1993, Comparison of competitive and uncompetitive NMDA receptor antagonists with regard to monoaminergic neuronal activity and behavioral effects in rats, Eur J Pharmacol, 242, 263, 10.1016/0014-2999(93)90250-L Maes, 1994, Hypozincemia in depression, J Affect Disord, 2, 135, 10.1016/0165-0327(94)90117-1 Maes, 1997, Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness, Biol Psychiatry, 42, 349, 10.1016/S0006-3223(96)00365-4 Maes, 1999, Lower serum zinc in major depression in relation to changes in serum acute phase proteins, J Affect Disord, 56, 189, 10.1016/S0165-0327(99)00011-7 Martin, 1988, Systemic PCP treatments elevates bran extracellular 5HT: a microdialysis study in awake rats, Neuroreport, 9, 2985, 10.1097/00001756-199809140-00012 Mathie, 2006, Zinc and copper pharmacological probes and endogenous modulators of neuronal excitability, Pharmacol Ther, 111, 567, 10.1016/j.pharmthera.2005.11.004 McLoughlin, 1990, Zinc in depressive disorder, Acta Psychiatr Scand, 82, 451, 10.1111/j.1600-0447.1990.tb03077.x Nowak, 1999, Serum trace elements in animal models and human depression. Part I zinc, Hum Psychopharmacol Clin Exp, 14, 83, 10.1002/(SICI)1099-1077(199903)14:2<83::AID-HUP74>3.0.CO;2-6 Nowak, 2003, Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study, Pol J Pharmacol, 55, 1143 Nowak, 2003, Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats, Brain Res Bull, 61, 159, 10.1016/S0361-9230(03)00104-7 Nowak, 2004, Zinc treatment induces cortical brain-derived neurotrophic factor gene expression, Eur J Pharmacol, 492, 57, 10.1016/j.ejphar.2004.03.038 O'Leary, 2007, Depletion of serotonin and catecholamines block the acute behavioural response to different classes of antidepressant drugs in the mouse tail suspension test, Psychopharmacol, 192, 357, 10.1007/s00213-007-0728-9 Pawlowski, 1985, Ro 11-2465 (cyan-imipramine), citalopram and their N-desmethyl metabolites: effects on the uptake of 5-hydroxytryptamine and noradrenaline in vivo and related pharmacological activities, Psychopharmacol, 86, 156, 10.1007/BF00431702 Pittenger, 2007, The NMDA receptor as a therapeutic target in major depressive disorder, CNS Neurolog Disord — Drug Targets, 6, 101, 10.2174/187152707780363267 Poleszak, 2007, Modulation of antidepressant-like activity of magnesium by serotonergic system, J Neural Transm, 114, 1129, 10.1007/s00702-007-0714-8 Poleszak, 2008, d-Serine, a selective glycine/NMDA receptor agonist, antagonizes the antidepressant-like effects of magnesium and zinc in mice, Pharmacol Rep., 60, 996 Porsolt, 1978, Behavioral despair in rat: a new model sensitive to antidepressant treatments, Eur J Pharmacol, 47, 379, 10.1016/0014-2999(78)90118-8 Porsolt, 1977, Behavioral despair in mice: a primary screening test for antidepressants, Arch Int Pharmacodyn Ther, 29, 327 Pozzi, 1999, Fluoxetine increases extracellular dopamine in the prefrontal cortex by a mechanism not dependent on serotonin: a comparison with citalopram, J Neurochem, 73, 1051, 10.1046/j.1471-4159.1999.0731051.x Redrobe, 1997, Partial role of 5-HT2 and 5-HT3 receptors in the activity of antidepressants in the forced swimming test, Eur J Pharmacol, 325, 129, 10.1016/S0014-2999(97)00115-5 Redrobe, 1996, The role of 5-HT1A and 5-HT1B receptors in antidepressant drug actions in the mouse forced swimming test, Eur J Pharmacol, 318, 213, 10.1016/S0014-2999(96)00772-8 Rosa, 2003, Involvement of NMDA receptors and l-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice, Behav Brain Res, 144, 87, 10.1016/S0166-4328(03)00069-X Schlegel-Zawadzka, 2000, Effect of depression and of antidepressant therapy on serum zinc levels — a preliminary clinical study, 607 Schildkraut, 1965, The catecholamine hypothesis of affective disorders: a review of supporting evidence, Am J Psychiatry, 122, 509, 10.1176/ajp.122.5.509 Smart, 1994, Modulation of inhibitory and excitatory amino acid receptor ion channels by zinc, Prog Neurobiol, 42, 393, 10.1016/0301-0082(94)90082-5 Sowa-Kućma, 2008, Antidepressant-like activity of zinc: further behavioral and molecular evidence, J Neural Transm, 115, 1621, 10.1007/s00702-008-0115-7 Szewczyk, 2002, Interaction of zinc with antidepressants in the forced swimming test in mice, Pol J Pharmacol, 54, 681 Szewczyk, 2008, Antidepressant activity of zinc and magnesium in view of the current hypotheses of antidepressant action, Pharmacol Rep, 60, 588 Takeda, 2000, Movement of zinc and its functional significance in the brain, Brain Res Bull, 34, 137, 10.1016/S0165-0173(00)00044-8 Takeda, 2008, Enhancement of social isolation-induced aggressive behavior of young mice by zinc deficiency, Life Sci, 82, 909, 10.1016/j.lfs.2008.02.005 Tassabehji, 2008, Zinc deficiency induces depression-like symptoms in adult rats, Physiol Behav, 95, 365, 10.1016/j.physbeh.2008.06.017 Versiani, 1999, Reboxetine, a unique selective NRI, prevent relapse and recurrence in long-term treatment of major depressive disorder, J Clin Psychiatry, 60, 400, 10.4088/JCP.v60n0610 Wojcik, 2006, Antepartum/postpartum depressive symptoms and serum zinc and magnesium levels, Pharmacol Rep, 58, 571 Yan, 1997, Dizocilpine (MK-801) increases not only dopamine but also serotonin and norepinephrine transmissions in the nucleus accumbens as measured by microdialysis in freely moving rats, Brain Res, 765, 149, 10.1016/S0006-8993(97)00568-4